1 |
Stanciu IM, Parosanu AI, Orlov-Slavu C, Iaciu IC, Popa AM, Olaru CM, Pirlog CF, Vrabie RC, Nitipir C. Mechanisms of Resistance to CDK4/6 Inhibitors and Predictive Biomarkers of Response in HR+/HER2-Metastatic Breast Cancer-A Review of the Literature. Diagnostics (Basel) 2023;13. [PMID: 36900131 DOI: 10.3390/diagnostics13050987] [Reference Citation Analysis]
|
2 |
Lin X, Chen D, Chu X, Luo L, Liu Z, Chen J. Oxypalmatin regulates proliferation and apoptosis of breast cancer cells by inhibiting PI3K/AKT signaling and its efficacy against breast cancer organoids. Phytomedicine 2023. [DOI: 10.1016/j.phymed.2023.154752] [Reference Citation Analysis]
|
3 |
Li J, Liu X, Chen L, Zhu X, Yu Z, Dong L, Zhao X, Zou H, Wei Q, Feng Y, Zhu Y, Chai K, Li Q, Li M. Isopimaric acid, an ion channel regulator, regulates calcium and oxidative phosphorylation pathways to inhibit breast cancer proliferation and metastasis. Toxicol Appl Pharmacol 2023;462:116415. [PMID: 36754215 DOI: 10.1016/j.taap.2023.116415] [Reference Citation Analysis]
|
4 |
Occhiuzzi MA, Lico G, Ioele G, De Luca M, Garofalo A, Grande F. Recent advances in PI3K/PKB/mTOR inhibitors as new anticancer agents. Eur J Med Chem 2023;246:114971. [PMID: 36462440 DOI: 10.1016/j.ejmech.2022.114971] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Luo F, Manse Y, Chaipech S, Pongpiriyadacha Y, Muraoka O, Morikawa T. Phytochemicals with Chemopreventive Activity Obtained from the Thai Medicinal Plant Mammea siamensis (Miq.) T. Anders.: Isolation and Structure Determination of New Prenylcoumarins with Inhibitory Activity against Aromatase. IJMS 2022;23:11233. [DOI: 10.3390/ijms231911233] [Reference Citation Analysis]
|